Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Bioadhesives: A Multifunctional Origami Patch for Minimally Invasive Tissue Sealing (Adv. Mater. 11/2021)
Yuk, Hyunwoo , Wu, Sarah Jinhui , Wu, Jingjing , Nabzdyk, Christoph S. , Zhao, Xuanhe

Mayo Clinic

Advanced Materials | March 16, 2021 | Volume: 33 | Issue: 11 | Pages: No page available

10.1002/adma.202170083 Get It

Extrapolation of ACOSOG Z0011 trial results—A survey of breast cancer providers
Weiss, Anna , Cooley, Victoria , Al‐Hilli, Zahraa , Poorvu, Nancy , Haffty, Bruce G. , Nelson, Heidi , Blair, Sarah L. , Boughey, Judy, Ballman, Karla V. , Hunt, Kelly K. , Boughey, Judy C.

Mayo Clinic

The Breast Journal | March 15, 2021 | Volume: 27 | Issue: 6 | Pages: 537-542

10.1111/tbj.14226 | PMID 33720478 Get It

Segregation of functional networks is associated with cognitive resilience in Alzheimer’s disease
Ewers, Michael , Luan, Ying , Frontzkowski, Lukas , Rubinski, Anna , Dichgans, Martin , Hassenstab, Jason , Gordon, Brian A. , Chhatwal, Jasmeer P. , Xiong, Chengjie , Morris, John C. , Goate, Alison , Fagan, Anne M. , Berman, Sarah , Chui, Helena C., Cruchaga, Carlos , Farlow, Marty, Graff‐Radford, Neill R. , Martins, Ralph N. , Mori, Hiroshi , Perrin, Richard J. , Xiong, Chengjie , Fox, Nick C. , O’Connor, Antoinette , Salloway, Stephen , Danek, Adrian , Büerger, Katharina , Bateman, Randall J. , Habeck, Christian , Network, for the Alzheimer’s Disease Neuroimaging Initiative and the Dominantly Inherited Alzheimer, Vöglein, Jonathan , Gordon, Brian A , O'Connor, Antoinette , Stern, Yaakov , Franzmeier, Nicolai , Dichgans, Martin , Cruchaga, Carlos , Bateman, Randall J , Vöglein, Jonathan , Xiong, Chengjie , Fox, Nick C , Hassenstab, Jason , Morris, John C , Goate, Alison M , Berman, Sarah , Neitzel, Julia , Schofield, Peter R. , Benzinger, Tammie L.S. , Karch, Celeste M. , McDade, Eric , Allegri, Ricardo , Chui, Helena C. , Jucker, Mathias , Lee, Jae‐Hong , Rossor, Martin N. , Stern, Yaakov , Franzmeier, Nicolai , Network, for the Alzheimer’s Disease Neuroimaging Initiative and the Dominantly Inherited Alzheimer

Mayo Clinic

Brain | March 12, 2021 | Volume: 144 | Issue: 7 | Pages: 2176-2185

10.1093/brain/awab112 | PMID 33725114 Get It

Abstract Cognitive resilience is an important modulating factor of cognitive decline in Alzheimer’s disease, but the functional brain mechanisms that support cognitive resilience remain elusive. Given previous findings in normal ageing, we tested the hypothesis that higher segregation of the brain’s connectome into distinct functional networks represents a functional mechanism underlying cognitive resilience in Alzheimer’s disease. Using resting-state functional MRI, we assessed both resting-state functional MRI global system segregation, i.e. the balance of between-network to within-network connectivity, and the alternate index of modularity Q as predictors of cognitive resilience. We performed all analyses in two independent samples for validation: (i) 108 individuals with autosomal dominantly inherited Alzheimer’s disease and 71 non-carrier controls; and (ii) 156 amyloid-PET-positive subjects across the spectrum of sporadic Alzheimer’s disease and 184 amyloid-negative controls. In the autosomal dominant Alzheimer’s disease sample, disease severity was assessed by estimated years from symptom onset. In the sporadic Alzheimer’s sample, disease stage was assessed by temporal lobe tau-PET (i.e. composite across Braak stage I and III regions). In both samples, we tested whether the effect of disease severity on cognition was attenuated at higher levels of functional network segregation. For autosomal dominant Alzheimer’s disease, we found higher functional MRI-assessed system segregation to be associated with an attenuated effect of estimated years from symptom onset on global cognition (P = 0.007). Similarly, for patients with sporadic Alzheimer’s disease, higher functional MRI-assessed system segregation was associated with less decrement in global cognition (P = 0.001) and episodic memory (P = 0.004) per unit increase of temporal lobe tau-PET. Confirmatory analyses using the alternate index of modularity Q revealed consistent results. In conclusion, higher segregation of functional connections into distinct large-scale networks supports cognitive resilience in Alzheimer’s disease.
Associations of physician burnout with organizational electronic health record support and after-hours charting
Eschenroeder, H C, Manzione, Lauren , Bice, Connor P. , CASH, R. S. G., Duda, Cole, Joseph, Craig , Lee, John S., Maneker, Amy, Poterack, Karl A. , Rahman, Sarah , Jeppson, Jacob, Adler‐Milstein, Julia , Bice, Connor, Cash, Robert, Longhurst, Chris

Mayo Clinic

Journal of the American Medical Informatics Association | March 11, 2021 | Volume: 28 | Issue: 5 | Pages: 960-966

10.1093/jamia/ocab053 | PMID 33880534 Get It

Abstract In 2017, 43.9% of US physicians reported symptoms of burnout. Poor electronic health record (EHR) usability and time-consuming data entry contribute to burnout. However, less is known about how modifiable dimensions of EHR use relate to burnout and how these associations vary by medical specialty. Using the KLAS Arch Collaborative’s large-scale nationwide physician (MD/DO) data, we used ordinal logistic regression to analyze associations between self-reported burnout and after-hours charting and organizational EHR support. We examined how these relationships differ by medical specialty, adjusting for confounders. Physicians reporting ≤ 5 hours weekly of after-hours charting were twice as likely to report lower burnout scores compared to those charting ≥6 hours (aOR: 2.43, 95% CI: 2.30, 2.57). Physicians who agree that their organization has done a great job with EHR implementation, training, and support (aOR: 2.14, 95% CI: 2.01, 2.28) were also twice as likely to report lower scores on the burnout survey question compared to those who disagree. Efforts to reduce after-hours charting and improve organizational EHR support could help address physician burnout.
Use of polysomnography and home sleep apnea tests for the longitudinal management of obstructive sleep apnea in adults: an American Academy of Sleep Medicine clinical guidance statement
Caples, Sean M., Anderson, William, Calero, Karel , Howell, Michael J. , Hashmi, Sarah D., Howell, Michael J

Mayo Clinic

Journal of Clinical Sleep Medicine | March 11, 2021 | Volume: 17 | Issue: 6 | Pages: 1287-1293

10.5664/jcsm.9240 | PMID 33704050 Get It

Theragnostic chromosomal rearrangements in treatment‐naive pancreatic ductal adenocarcinomas obtained via endoscopic ultrasound
Murphy, Stephen J. , Levy, Michael J. , Smadbeck, James B. , Karagouga, Giannoula, McCune, Alexa, Harris, Faye R. , Udell, Julia , Johnson, Sarah H. , Kerr, Sarah E. , Cheville, John C. , Kipp, Benjamin R. , Vasmatzis, George , Gleeson, Ferga C. , McCune, Alexa F, Udell, Julia B

Mayo Clinic

Journal of Cellular and Molecular Medicine | March 11, 2021 | Volume: 25 | Issue: 8 | Pages: 4110-4123

10.1111/jcmm.16381 | PMID 33704908 Get It

AbstractA crucial mutational mechanism in malignancy is structural variation, in which chromosomal rearrangements alter gene functions that drive cancer progression. Herein, the presence and pattern of structural variations were investigated in twelve prospectively acquired treatment‐naïve pancreatic cancers specimens obtained via endoscopic ultrasound (EUS). In many patients, this diagnostic biopsy procedure and specimen is the only opportunity to identify somatic clinically relevant actionable alterations that may impact their care and outcome. Specialized mate pair sequencing (MPseq) provided genome‐wide structural variance analysis (SVA) with a view to identifying prognostic markers and possible therapeutic targets. MPseq was successfully performed on all specimens, identifying highly rearranged genomes with complete SVA on all specimens with > 20% tumour content. SVA identified chimeric fusion proteins and potentially immunogenic readthrough transcripts, change of function truncations, gains and losses of key genes linked to tumour progression. Complex localized rearrangements, termed chromoanagenesis, with broad pattern heterogeneity were observed in 10 (83%) specimens, impacting multiple genes with diverse cellular functions that could influence theragnostic evaluation and responsiveness to immunotherapy regimens. This study indicates that genome‐wide MPseq can be successfully performed on very limited clinically EUS obtained specimens for chromosomal rearrangement detection and potential theragnostic targets.
Terminal Delirium in Hospice: The Experiences and Perspectives of Caregivers Providing Care to Terminally Ill Patients in Home Settings
Soroka, Jacek T. , Fling, Krista J., Heibel, Jennifer M., Kutcher, Gregory R., Ward, Sarah , Ward, Sarah J

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | March 9, 2021 | Volume: 39 | Issue: 1 | Pages: 27-33

10.1177/10499091211000729 | PMID 33685252 Get It

Objectives: Little is known about the experiences of caregivers who provide care to persons with terminal delirium (TD) in home settings. This scarcity of information is suggestive that further research is needed about care for hospice patients with delirium in the home and community. Aim: To elicit views, feelings, and end-of-life care experiences of primary caregivers assisting dying persons with TD in hospice at home. Design: Qualitative, exploratory, cross-sectional study design was chosen. In-depth semistructured interviews explored caregiver experiences in caring for persons with TD. Qualitative thematic framework analysis was used. Participants: Fifteen bereaved adult primary caregivers who received services from a hospice care program affiliated with a large nonprofit health system in the US Midwest. Results: Caregiver experiences were broad and reflected 4 major themes: symptomology, coping, effective and noneffective interventions, and support. The most distressing factors for caregivers were behaviors and symptomology of TD. They did not know what to say, how to respond, and how best to behave with someone who had delirium. Many caregivers had the impression that medication does not lessen delirium symptoms and that nonpharmacologic interventions are effective and beneficial only when they were important and meaningful to patients before delirium onset. Conclusions: This study added new knowledge from direct and personal perspectives of caregivers providing end-of-life care to patients at home. Understanding developed about provision of care to someone with TD in home hospice. Improved comprehension of caregiver experiences can help professional hospice and palliative care staff better prepare caregivers for when patients have TD.
Guidelines for Perioperative Care for Emergency Laparotomy Enhanced Recovery After Surgery (ERAS) Society Recommendations: Part 1—Preoperative: Diagnosis, Rapid Assessment and Optimization
Peden, Carol J. , Aggarwal, Geeta , Aitken, Robert , Anderson, I D , Cooper, Zara , Dhesi, Jugdeep , French, W. Brenton, Hammarqvist, Folke , Hare, Sarah P., Havens, Joaquim M. , Holena, Daniel N. , Hübner, Martin , Kim, Jeniffer S. , Lees, Nicholas P. , Ljungqvist, Olle , Lobo, Dileep N. , Quiney, Nial , Wick, Elizabeth C. , Young‐Fadok, Tonia M., Scott, Michael J. , Cooper, Zara , Aitken, Robert J , Cooper, Zara , Lees, Nicholas P , Lobo, D N , Mohseni, Shahin , Ordoñez, Carlos A , Urman, Richard D , Young-Fadok, Tonia, Scott, M J , Peden, Carol J , Hübner, Martin , Foss, Nicolai Bang , Grant, Michael Conrad , Mohseni, Shahin , Ordóñez, Carlos A. , Wu, Christopher L

Mayo Clinic

World Journal of Surgery | March 6, 2021 | Volume: 45 | Issue: 5 | Pages: 1272-1290

10.1007/s00268-021-05994-9 | PMID 33677649 Get It

Abstract Background Enhanced Recovery After Surgery (ERAS) protocols reduce length of stay, complications and costs for a large number of elective surgical procedures. A similar, structured approach appears to improve outcomes, including mortality, for patients undergoing high‐risk emergency general surgery, and specifically emergency laparotomy. These are the first consensus guidelines for optimal care of these patients using an ERAS approach. Methods Experts in aspects of management of the high‐risk and emergency general surgical patient were invited to contribute by the International ERAS® Society. Pubmed, Cochrane, Embase, and MEDLINE database searches on English language publications were performed for ERAS elements and relevant specific topics. Studies on each item were selected with particular attention to randomized controlled trials, systematic reviews, meta‐analyses and large cohort studies, and reviewed and graded using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system. Recommendations were made on the best level of evidence, or extrapolation from studies on non‐emergency patients when appropriate. The Delphi method was used to validate final recommendations. The guideline has been divided into two parts: Part 1—Preoperative Care and Part 2—Intraoperative and Postoperative management. This paper provides guidelines for Part 1. Results Twelve components of preoperative care were considered. Consensus was reached after three rounds. Conclusions These guidelines are based on the best available evidence for an ERAS approach to patients undergoing emergency laparotomy. Initial management is particularly important for patients with sepsis and physiological derangement. These guidelines should be used to improve outcomes for these high‐risk patients.
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Benson, Al B. , Al-Hawary, Mahmoud M. , Arain, Mustafa A., Chen, Yi‐Jen , Ciombor, Kristen K. , Cooper, Harry S. , Deming, Dustin A. , Farkas, Linda M., Garrido‐Laguna, Ignacio , Grem, Jean L. , Hecht, J. Randolph, Hoffe, Sarah E. , Hunt, Steven R., Johung, Kimberly L. , Kirilcuk, Natalie, Krishnamurthi, Smitha , Messersmith, Wells A. , Meyerhardt, Jeffrey A. , Mulcahy, Mary F. , Nurkin, Steven, Overman, Michael J. , Patel, Hitendra , Pedersen, Katrina S. , Shibata, David , Skibber, John M., Sofocleous, Constantinos T. , Stotsky‐Himelfarb, Eden, Willett, Christopher G. , Gregory, Kristina M., Gurski, Lisa A., Hubbard, Joleen, Meyerhardt, Jeffrey A , Pedersen, Katrina , Venook, Alan P. , Cohen, Stacey A. , Gunn, Andrew, Hubbard, Joleen M. , Miller, Eric D. , Parikh, Aparna R. , Patel, Hitendra, Saltz, Leonard B. , Schneider, Charles John , Stoffel, Elena M.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | March 5, 2021 | Volume: 19 | Issue: 3 | Pages: 329-359

10.6004/jnccn.2021.0012 | PMID 33724754 Get It

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer focuses on systemic therapy options for the treatment of metastatic colorectal cancer (mCRC), because important updates have recently been made to this section. These updates include recommendations for first-line use of checkpoint inhibitors for mCRC, that is deficient mismatch repair/microsatellite instability-high, recommendations related to the use of biosimilars, and expanded recommendations for biomarker testing. The systemic therapy recommendations now include targeted therapy options for patients with mCRC that is HER2-amplified, or BRAF V600E mutation–positive. Treatment and management of nonmetastatic or resectable/ablatable metastatic disease are discussed in the complete version of the NCCN Guidelines for Colon Cancer available at NCCN.org . Additional topics covered in the complete version include risk assessment, staging, pathology, posttreatment surveillance, and survivorship.